
Eventide Healthcare & Life Sciences Fd Cl N
ETNHX
Updated: 22/09/2026, 09:32:44
Under normal market conditions, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. It may invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts ("ADRs"). The fund may invest in securities of companies of any market capitalization.
No summaries found.
- Share price
- $55.82
- Market cap
- $1.84B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 27/12/2012
- Beta
- 1.01
- Last dividend
- $0.00
- Day range
- $55.82 – $56.02
- 52-week range
- $39.47 – $60.71
- 1-day performance
- -0.36%
- 1-year performance
- 41.42%
- Current drawdown (1Y)
- -8.05%
- CIK
- 0001355064
- CUSIP
- 62827M607
- ISIN
- US62827M6075
- Created
- 07/12/2025, 03:51:13
- Last update
- 22/09/2026, 09:32:44
Track Eventide Healthcare & Life Sciences Fd Cl N with an AI analyst
See which prediction-market events move ETNHX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.